Keene & Associates, Inc. Royalty Pharma PLC Transaction History
Keene & Associates, Inc.
- $119 Million
- Q4 2024
A detailed history of Keene & Associates, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Keene & Associates, Inc. holds 19,420 shares of RPRX stock, worth $641,054. This represents 0.42% of its overall portfolio holdings.
Number of Shares
19,420
Previous 19,050
1.94%
Holding current value
$641,054
Previous $538,000
7.99%
% of portfolio
0.42%
Previous 0.41%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.3 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$760 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$560 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$467 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...